Month: May 2023

FDA grants appeal and files NDABURLINGTON, Mass., May 01, 2023 (GLOBE NEWSWIRE) — . (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central …

Teva Pharmaceuticals and MedinCell have received approval from the US FDA for Uzedy (risperidone) extended-release injectable suspension …

The FDA has approved the New Drug Application (NDA) for ABILIFY ASIMTUFII, a once-every-two-months injection for the treatment of …